Androgenetic alopecia and other hair-loss conditions result from follicle miniaturisation, stem-cell exhaustion within the dermal papilla, and inflammatory signalling that disrupts the hair growth cycle. Exosomes derived from umbilical-cord fibroblasts and mesenchymal stem cells contain growth factors (bFGF, VEGF, HGF), microRNAs (miR-29b regulating collagen cross-linking), and lipid mediators that promote angiogenesis, collagen deposition, and hair-follicle neogenesis in preclinical models. Sixteen registered clinical trials and four actively recruiting studies assess topical, intradermal, and systemic exosome formulations alongside platelet-rich plasma and conventional minoxidil or finasteride regimens.
Representative trials document hair density and thickness metrics using phototrichography and image analysis. Phase I–II cohorts report mean hair density increase of 15–35% over baseline in 50–65% of participants within 4–6 months of intradermal exosome injection or topical serum application. Terminal hair transition (vellus to terminal fibre diameter) occurs in 30–45%. Blinded assessor ratings and patient self-assessment show concordance in approximately 60–70% of cases. Durability studies extend to 12–18 months; some re-growth stabilises, whilst other patients require re-treatment.
Hair-loss exosome treatments in Sofia clinics range €3,000–6,500 for complete courses, typically involving 4–6 intradermal injections spaced monthly, supplemented by topical exosome serum (applied 2–3 times weekly for 3–6 months). Cost drivers include exosome concentration, cell-culture scale-up, sterilisation, and clinical assessment (scalp imaging, follicle counting). Combination with platelet-rich plasma or growth-factor cocktails adds €500–1,500 per session.
Cell therapy for Hair Loss & Restoration is offered as an individualised, physician-led programme. In the EU and US it is regulated as an advanced therapy rather than an approved 'cure' for this condition — it is currently investigational. That status is exactly why EU GMP oversight, characterised cells and honest evidence matter.
Most protocols involve one treatment visit with one or more infusions over a few days; some patients return for a second cycle. The exact plan — cell type, dose and route — is set only after a clinician reviews your records.
Eligibility depends on condition stage, age and overall health. A clinic should review your records before recommending anything and tell you honestly if you are not a good candidate. Our candidacy self-check gives an indicative read in 60 seconds.
An indicative Hair Loss & Restoration programme is €3,000–€8,000 for treatment (it varies by procedure). Add travel and hotel with our calculator for your true all-in cost — typically a fraction of US, UK or German pricing.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
← Back to Hair Loss & Restoration overview · Hair Loss & Restoration cost →
Medicina regenerativa certificada GMP en el corazón de la UE — desde 3.000–8.000 €, una fracción de los precios de EE. UU. o Alemania. Protocolos personalizados para pacientes de más de 50 países.
Evaluación médica gratuita